In Response to "Serum Tumor Marker Use in Patients With Advanced Solid Tumors"
J Oncol Pract
.
2016 Mar;12(3):273-4.
doi: 10.1200/JOP.2015.009241.
Epub 2016 Feb 2.
Authors
Farshid Dayyani
1
,
Dave Morgenstern
2
,
Stefan Holdenrieder
3
Affiliations
1
Roche Diagnostics International, Rotkreuz, Switzerland
[email protected]
.
2
Roche Diagnostics International, Rotkreuz, Switzerland.
3
University of Bonn, Bonn, Germany.
PMID:
26837562
DOI:
10.1200/JOP.2015.009241
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers, Tumor*
Humans
Neoplasms*
Substances
Biomarkers, Tumor